Systemic lupus erythematosus within the first two decades of life

The American Journal of Medicine

Volumn 62, Issue 1, 1977, Pages 99-117

  Fish, Alfred J ^a   Blau, Edward B ^a   Westberg, N Gunnar ^a   Burke, Barbara A ^a   Vernier, Robert L ^a   Michael, Alfred F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

DIAGNOSIS; EPIDEMIOLOGY; GLOMERULONEPHRITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MORTALITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AZATHIOPRINE; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INFANT; KIDNEY; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDNISONE;

EID: 0017328599     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(77)90355-2     Document Type: Review

References (59)

1. Presentation of two bone marrow elements, the “tart” cell and “L.E.” cell
2. Systemic lupus erythematosus in childhood
3. Systemic lupus erythematosus in childhood
4. Systemic lupus erythematosus' Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases
5. Systemic lupus erythematosus in childhood
6. Lupus erythematosus
7. Treatment of systemic lupus erythematosus complicated by nephritis in children
8. Systemic lupus erythematosus in childhood
9. The clinical picture of systemic lupus erythematosus
10. Lupus nephritis. A clinical and pathologic study based on renal biopsies
11. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis
12. The natural history of the renal manifestations of systemic lupus erythematosus
13. The clinical course of the proliferative and membranous forms of lupus nephritis
14. The natural history of systemic lupus erythematosus by prospective analysis
15. Duration and death in systemic lupus erythematosus' An analysis of 249 cases
16. The course of lupus nephritis. A clinical-pathological correlation of fifty patients
17. The clinical course of lupus nephritis. Relationship to the renal histologic findings
18. Lupus nephritis. Clinical course in relation to treatment
19. Renal insufficiency in lupus nephritis
20. Steroid therapy of systemic lupus erythematosus based on immunologic considerations
21. Immunosuppressive therapy of chronic renal disease
22. Immunosuppressive therapy of proliferative glomerulonephritis in children
23. Comparison of azathioprine prednisone and heparin alone or combined in treating lupus nephritis
24. Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus
25. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine
26. The effect of treatment with prednisone and nitrogen mustard on the renal lesions and life span of patients with lupus glomerulonephritis
27. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus
28. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis
29. Preliminary criteria for the classification of systemic lupus erythematosus
30. C2 deficiency, Development of lupus erythematosus
31. Properdin and C3 proactivator. Alternate pathway components in human glomerulonephritis
32. Immunologic phenomena in patients with systemic lupus erythematosus
33. Acute poststreptococcal glomerulonephritis, immune deposit disease
34. Chromatographic purification of tetramethylrhodamine immune globulin conjugates and their use in the cellular localization of rabbit γ globulin in polypeptide chain
35. Renal histology and clinical course of systemic lupus erythematosus
36. Progression of mesangial and focal to diffuse lupus nephritis
37. Maximum utilization of the life table method in analyzing survival
38. Avascular necrosis of bone in systemic lupus erythematosus
39. Renal histologic findings in systemic lupus erythematosus
40. Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus
41. Pathology of the kidney in systemic lupus erythematosus. Serial renal biopsy studies and the effects of therapy on kidney lesions
42. Glomerulonephritis in SLE
43. Progression from minimal or focal to diffuse proliferative lupus nephritis
44. DNA: anti-DNA complexes. Their detection in systemic lupus erythematosus sera
45. Pathogenesis of the glomerulonephritis of NZB/W mice
46. Experimental glomerulonephritis The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis
47. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen
48. The effect of azathioprine on lupus glomerulonephritis
49. Effect of azathioprine on renal histology and function in lupus nephritis
50. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical histological and immunological changes with therapy
51. Treatment of lupus nephritis with azathioprine
52. Treatment of lupus nephritis with prednisone and azathioprine
53. Lupus nephritis: long-term follow-up
54. Autoimmune aspects of systemic lupus erythematosus and the forbidden clone hypothesis. A revision
55. The prognosis of childhood systemic lupus erythematosus
56. Nephritis in systemic lupus erythematosus in children